Share on Facebook Share on LinkedIn Share on Twitter Bookmark this page Email This Page Print This Page
Hogan Lovells Publications
"Executive Order Overturning Embryonic Stem Cell Funding Ban Creates Varied Opportunities and Challenges." Pharmaceutical and Biotechnology Update, Hogan & Hartson LLP, 20 March 2009

Edward L. Korwek, Michael N. Druckman, Marcy Wilder, Brooke Bumpers, Robert J. Kenney,
Veronica Valdivieso, Gary D. Uy

Download PDF

On March 9, 2009, President Obama signed Executive Order 13505, allowing federal funding of human embryonic stem cell (hESC) research. The order removes restrictions imposed by former President Bush on August 9, 2001, and will allow the National Institutes of Health (NIH) to become a major new source of funding for hESC research. By signaling the Obama administration’s support for this research, the order may also be a catalyst for new investment and innovation in this area, which holds enormous growth potential.